share_log

StockNews.com Begins Coverage on Blonder Tongue Laboratories (NYSE:BDR)

Financial News Live ·  Jul 19, 2022 01:31

StockNews.com started coverage on shares of Blonder Tongue Laboratories (NYSE:BDR – Get Rating) in a research report released on Saturday. The firm issued a hold rating on the stock.

Blonder Tongue Laboratories Price Performance

The company's fifty day moving average is $0.36. Blonder Tongue Laboratories has a twelve month low of $0.28 and a twelve month high of $1.91. The firm has a market capitalization of $4.13 million, a price-to-earnings ratio of -4.43 and a beta of 0.55. The company has a quick ratio of 0.38, a current ratio of 1.11 and a debt-to-equity ratio of 0.64.

Get Blonder Tongue Laboratories alerts:

Blonder Tongue Laboratories (NYSE:BDR – Get Rating) last issued its quarterly earnings data on Friday, May 6th. The company reported ($0.09) EPS for the quarter. Blonder Tongue Laboratories had a negative return on equity of 18.69% and a negative net margin of 4.14%. The company had revenue of $3.34 million for the quarter.

Blonder Tongue Laboratories Company Profile

(Get Rating)

Blonder Tongue Laboratories, Inc, a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QPSK and 8PSK, and QAM transcoders.

Featured Stories

  • Get a free copy of the StockNews.com research report on Blonder Tongue Laboratories (BDR)
  • Is it Time to Cash Out Novavax Stock?
  • Should you buy Bank of America Stock After Its Q2 Earnings Report?
  • Monthly Dividend Stocks Can Provide Solid Income
  • AMC Entertainment Is On Track For Blockbuster Results
  • Why Did State Street's Stock Rally Despite Weaker Earnings?

Receive News & Ratings for Blonder Tongue Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blonder Tongue Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment